Quantitative analysis of IGF-1R expression in FFPE human rhabdomyosarcoma tumor tissue by mass spectrometry.

被引：0
|
作者：
Malempati, S.
Hembrough, T. A.
Thyparambil, S.
Cao, L.
Darfler, M.
Krizman, D.
Hawkins, D. S.
Skapek, S.
Helman, L. J.
Burrows, J.
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Express Pathol Inc, Rockville, MD USA
[3] NCI, Bethesda, MD 20892 USA
[4] Univ Washington, Dept Pediat, Seattle Childrens Hosp, Seattle, WA 98195 USA
[5] Univ Chicago, Chicago, IL 60637 USA
[6] NCI, Ctr Canc Res, Bethesda, MD 20892 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.10069
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10069
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Somatostatin (SST) and octreotide (OCT) inhibit IGF-1 mediated tyrosine phosphorylation of IGF-1R β and induction of VEGF gene expression in human RPE cells.
    Klisovic, DD
    Sall, JW
    O'Dorisio, MS
    Katz, SE
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S244 - S244
  • [32] Analysis of FFPE treated clinical tissue sections obtained from human intraocular malignancy, uveal melanoma by mass spectrometry imaging (MSI)
    Cole, Laura M.
    Mudhar, Hardeep S.
    Sisley, Karen
    Peck, Andrew
    Batey, Mike
    Claude, Emmanuelle
    Clench, Malcolm
    CANCER RESEARCH, 2016, 76
  • [33] Prognostic and predictive role of CXCR4, IGF-1R and Ezrin expression in localized synovial sarcoma: is chemotaxis important to tumor response?
    Emanuela Palmerini
    Maria Serena Benassi
    Irene Quattrini
    Laura Pazzaglia
    Davide Donati
    Stefania Benini
    Gabriella Gamberi
    Marco Gambarotti
    Piero Picci
    Stefano Ferrari
    Orphanet Journal of Rare Diseases, 10
  • [34] Multiplexed mass spectometic quantitation of HER1-3, cMET, and IGF1R in FFPE tumor samples: Implications for targeted therapy and resistance.
    Hembrough, Todd A.
    Liao, Wei-Li
    Thyparambil, Sheeno
    Darfler, Marlene
    Krizman, David
    Burrows, Jon
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [35] Prognostic and predictive role of CXCR4, IGF-1R and Ezrin expression in localized synovial sarcoma: is chemotaxis important to tumor response?
    Palmerini, Emanuela
    Benassi, Maria Serena
    Quattrini, Irene
    Pazzaglia, Laura
    Donati, Davide
    Benini, Stefania
    Gamberi, Gabriella
    Gambarotti, Marco
    Picci, Piero
    Ferrari, Stefano
    ORPHANET JOURNAL OF RARE DISEASES, 2015, 10
  • [36] High-throughput quantitative proteomics of human breast cancer tissue using 2D-differential in-gel electrophoresis and mass spectrometry.
    Sullivan, AG
    Russell, S
    Jordan, R
    Hooke, J
    Shriver, C
    Somiari, RI
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S164 - S164
  • [37] A label-free mass spectrometry method for relative quantitation of β-tubulin isotype expression in human tumor tissue
    Miller, Leah M.
    Yang, Chia-Ping Huang
    Xiao, Hui
    Isaac, Sylvie
    Seve, Pascal
    Dumontet, Charles
    Horwitz, Susan Band
    Angeletti, Ruth Hogue
    PROTEOMICS CLINICAL APPLICATIONS, 2012, 6 (9-10) : 502 - 506
  • [38] Evaluating the local expression pattern of IGF-1R in tumor tissues and the circulating levels of IGF-1, IGFBP-1, and IGFBP-3 in the blood of patients with different primary bone tumors
    Vaezi, Mohammad Amin
    Eghtedari, Amir Reza
    Safizadeh, Banafsheh
    Babaheidarian, Pegah
    Salimi, Vahid
    Adjaminezhad-Fard, Fatemeh
    Yarahmadi, Sahar
    Mirzaei, Alireza
    Rahbar, Mahtab
    Tavakoli-Yaraki, Masoumeh
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [39] Pharmacokinetic analysis of omomyc therapeutic protein in preclinical and human tumor tissue using targeted mass spectrometry
    Beaulieu, Marie-Eve
    Martinez-Martin, Sandra
    Mueller, Maik
    Feng, Yuehan
    Vowinckel, Jakob
    Lachaud, Antoine Amaury
    Soucek, Laura
    CANCER RESEARCH, 2024, 84 (06)
  • [40] The VHL tumor suppressor inhibits expression of the IGF1R and its loss induces IGF1R upregulation in human clear cell renal carcinoma
    J S P Yuen
    M E Cockman
    M Sullivan
    A Protheroe
    G D H Turner
    I S Roberts
    C W Pugh
    H Werner
    V M Macaulay
    Oncogene, 2007, 26 : 6499 - 6508
12345